throbber
11/7/2017
`
`Lymphocytopenia - Hematology and Oncology - Merck Manuals Professional Edition
`
`MMERCK(cid:98)MANUAL
`
`Professional / Hematology and Oncology / Leukopenias
`
`Lymphocytopenia
`
`Professional Version
`
`By Mary Territo, MD, Emeritus Professor of Medicine, Division of Hematology and Oncology,
`David Geffen School of Medicine at UCLA
`
`Lymphocytopenia is a total lymphocyte count of < 1000/μL in adults or < 3000/μL in children < 2 yr. Sequelae include
`opportunistic infections and an increased risk of malignant and autoimmune disorders. If the CBC reveals lymphocytopenia,
`testing for immunodeficiency and analysis of lymphocyte subpopulations should follow. Treatment is directed at the underlying
`disorder.
`
`The normal lymphocyte count in adults is 1000 to 4800/μL; in children < 2 yr, 3000 to 9500/μL. At age 6 yr, the lower limit of
`normal is 1500/μL.
`
`Both B and T cells are present in the peripheral blood; about 75% of the lymphocytes are T cells and 25% B cells. Because
`lymphocytes account for only 20 to 40% of the total WBC count, lymphocytopenia may go unnoticed when WBC count is checked
`without a differential.
`
`Clinical Calculator: Absolute Lymphocyte Count
`
`Almost 65% of blood T cells are CD4+ (helper) T cells. Most patients with lymphocytopenia have a reduced absolute number of T
`cells, particularly in the number of CD4+ T cells. The average number of CD4+ T cells in adult blood is 1100/μL (range, 300 to
`1300/μL), and the average number of cells of the other major T-cell subgroup, CD8+ (suppressor) T cells, is 600/μL (range, 100 to
`900/μL).
`
`Etiology
`
`Lymphocytopenia can be
`
`http://www.merckmanuals.com/professional/hematology-and-oncology/leukopenias/lymphocytopenia
`
`1/5
`
`Apotex v. Novartis
`IPR2017-00854
`NOVARTIS 2054
`
`

`

`11/7/2017
`
`Lymphocytopenia - Hematology and Oncology - Merck Manuals Professional Edition
`
`Acquired
`
`Inherited
`
`Acquired lymphocytopenia
`
`Acquired lymphocytopenia can occur with a number of other disorders (see Table: Causes of Lymphocytopenia). The most
`common causes include
`
`Protein-energy undernutrition
`
`AIDS and certain other viral infections
`
`Protein-energy undernutrition is the most common cause worldwide.
`
`AIDS is the most common infectious disease causing lymphocytopenia, which arises from destruction of CD4+ T cells infected
`with HIV. Lymphocytopenia may also reflect impaired lymphocyte production arising from destruction of thymic or lymphoid
`architecture. In acute viremia due to HIV or other viruses, lymphocytes may undergo accelerated destruction from active
`infections with the virus, may be trapped in the spleen or lymph nodes, or may migrate to the respiratory tract.
`
`Iatrogenic lymphocytopenia is caused by cytotoxic chemotherapy, radiation therapy, or the administration of antilymphocyte
`globulin (or other lymphocyte antibodies). Long-term treatment for psoriasis using psoralen and ultraviolet A irradiation may
`destroy T cells. Glucocorticoids can induce lymphocyte destruction.
`
`Lymphocytopenia may occur with lymphomas, autoimmune diseases such as SLE, rheumatoid arthritis, myasthenia gravis, and
`protein-losing enteropathy.
`
`Inherited lymphocytopenia
`
`Inherited lymphocytopenia (see Table: Causes of Lymphocytopenia) most commonly occurs in
`
`Severe combined immunodeficiency disorder
`
`Wiskott-Aldrich syndrome
`
`http://www.merckmanuals.com/professional/hematology-and-oncology/leukopenias/lymphocytopenia
`
`2/5
`
`

`

`11/7/2017
`
`Lymphocytopenia - Hematology and Oncology - Merck Manuals Professional Edition
`
`It may occur with inherited immunodeficiency disorders and disorders that involve impaired lymphocyte production. Other
`inherited disorders, such as Wiskott-Aldrich syndrome, adenosine deaminase deficiency, and purine nucleoside phosphorylase
`deficiency, may involve accelerated T-cell destruction. In many disorders, antibody production is also deficient.
`
`Causes of Lymphocytopenia
`
`Mechanism Examples
`
`AIDS
`
`Other infectious disorders, including hepatitis, influenza, TB, typhoid fever, and sepsis
`
`Dietary deficiency in patients with ethanol abuse, protein-energy undernutrition, or zinc deficiency
`
`Acquired
`
`Protein losing enteropathy
`
`Iatrogenic after use of cytotoxic chemotherapy, glucocorticoids, high-dose psoralen and ultraviolet A radiation therapy, lymphocyte antibody
`therapy, immunosuppressants, radiation therapy, or thoracic duct drainage
`
`Systemic disorders with autoimmune features (eg, aplastic anemia, Hodgkin lymphoma, myasthenia gravis, protein-losing enteropathy, RA, chronic
`kidney disease, sarcoidosis, SLE, thermal injury)
`
`Aplasia of lymphopoietic stem cells
`
`Ataxia-telangiectasia
`
`Cartilage-hair hypoplasia syndrome
`
`Hereditary
`
`Idiopathic CD4+ T lymphocytopenia
`
`Immunodeficiency with thymoma
`
`Severe combined immunodeficiency associated with a defect in the IL-2 receptor gamma-chain, deficiency of ADA or PNP, or an unknown defect
`
`Wiskott-Aldrich syndrome
`
`ADA =adenosine deaminase; PNP = purine nucleoside phosphorylase.
`
`http://www.merckmanuals.com/professional/hematology-and-oncology/leukopenias/lymphocytopenia
`
`3/5
`
`

`

`11/7/2017
`Symptoms and Signs
`
`Lymphocytopenia - Hematology and Oncology - Merck Manuals Professional Edition
`
`Lymphocytopenia per se generally causes no symptoms. However, findings of an associated disorder may include
`
`Absent or diminished tonsils or lymph nodes, indicative of cellular immunodeficiency
`
`Skin abnormalities (eg, alopecia, eczema, pyoderma, telangiectasia)
`
`Evidence of hematologic disease (eg, pallor, petechiae, jaundice, mouth ulcers)
`
`Generalized lymphadenopathy and splenomegaly, which may suggest HIV infection or Hodgkin lymphoma
`
`Lymphocytopenic patients experience recurrent infections or develop infections with unusual organisms. Pneumocystis jirovecii,
`cytomegalovirus, rubeola, and varicella pneumonias often are fatal. Lymphocytopenia is also a risk factor for the development of
`cancers and for autoimmune disorders.
`
`Diagnosis
`
`Clinical suspicion (repeated or unusual infections)
`
`CBC with differential
`
`Measurement of lymphocyte subpopulations and immunoglobulin levels
`
`Lymphocytopenia is suspected in patients with recurrent viral, fungal, or parasitic infections but is usually detected incidentally
`on a CBC. P. jirovecii, cytomegalovirus, rubeola, or varicella pneumonias with lymphocytopenia suggest immunodeficiency.
`Lymphocyte subpopulations are measured in patients with lymphocytopenia. Measurement of immunoglobulin levels should
`also be done to evaluate antibody production. Patients with a history of recurrent infections undergo complete laboratory
`evaluation for immunodeficiency, even if initial screening tests are normal.
`
`Treatment
`
`http://www.merckmanuals.com/professional/hematology-and-oncology/leukopenias/lymphocytopenia
`
`4/5
`
`

`

`11/7/2017
`
`Lymphocytopenia - Hematology and Oncology - Merck Manuals Professional Edition
`
`Treatment of associated infections
`
`Treatment of underlying disorder
`
`Sometimes IV immune globulin
`
`Possibly hematopoietic stem cell transplantation
`
`In acquired lymphocytopenias, lymphocytopenia usually remits with removal of the underlying factor or successful treatment of
`the underlying disorder. IV immune globulin is indicated if patients have chronic IgG deficiency, lymphocytopenia, and recurrent
`infections. Hematopoietic stem cell transplantation can be considered for all patients with congenital immunodeficiencies and
`may be curative.
`
`Key Points
`
`Lymphocytopenia is most often due to AIDS or undernutrition, but it also may be inherited or caused by various infections,
`drugs, or autoimmune disorders.
`
`Patients have recurrent viral, fungal, or parasitic infections.
`
`Lymphocyte subpopulations and immunoglobulin levels should be measured.
`
`Treatment is usually directed at the cause, but occasionally, IV immune globulin or, in patients with congenital
`immunodeficiency, stem cell transplantation is helpful.
`
`Last full review/revision November 2016 by Mary Territo, MD
`
`© 2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
`
`http://www.merckmanuals.com/professional/hematology-and-oncology/leukopenias/lymphocytopenia
`
`5/5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket